MYX mayne pharma group limited

NEXTSTELLIS® ORAL CONTRACEPTIVE, page-16

  1. 1,060 Posts.
    lightbulb Created with Sketch. 86
    https://hotcopper.com.au/data/attachments/5586/5586992-1b1d231bab469749116be04d3678b702.jpg
    1HFY23 36 M SPENT ON MARKETING Nexstellis alone .2HFY23 45.6 m SPENT ON all women health 5TXMD +Nexstellis .TXMD HAD 70 M OPEX now Mayne spent 45.6 on TXMD products inducing Nexstellis .Then 2hfy23 versus 1hfy23 Nexstellis has zeroOPEX
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.10
Change
0.030(0.59%)
Mkt cap ! $415.9M
Open High Low Value Volume
$5.13 $5.14 $5.10 $172.1K 33.69K

Buyers (Bids)

No. Vol. Price($)
3 953 $5.10
 

Sellers (Offers)

Price($) Vol. No.
$5.13 1316 7
View Market Depth
Last trade - 11.34am 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.